Performing Regulation: Transcending Regulatory Ritualism in HIV Clinics

By Heimer, Carol A.; Gazley, J. Lynn | Law & Society Review, December 1, 2012 | Go to article overview

Performing Regulation: Transcending Regulatory Ritualism in HIV Clinics


Heimer, Carol A., Gazley, J. Lynn, Law & Society Review


Sociolegal scholars suggest that regulatory encounters often are occasions for displaying a surface compliance decoupled from day-to-day practice. Yet ethnographic data from five highly regulated HIV clinics show that regulatory encounters open opportunities both for ritualism and-surprisingly-for transcending ritualism. Using a theatrical analogy, we argue that improv performance is the technology that enables regulatory inspectors and clinic staffto transcend ritualism. As regulatory encounters unfold, clinics' carefully prepared performances sometimes change into more cooperative interactions where inspectors and regulatees hash out details about how rules will be applied and even work together on reports for the regulators' supervisors. By "performing together," regulatory inspectors gain access to the clinic's backstage where they can assess clinic workers' deeper conformity to ethical and scientific norms. But such joint performances are less likely where cultural divides and material scarcity make it difficult for clinic staffto gain inspectors' trust.

In 2009, the FDA began the process of disqualifying Chicago HIV specialist Dr. Daniel Berger as a clinical researcher, charging that he had "failed to protect the rights, safety and welfare of subjects under [his] care, repeatedly or deliberately submitted false information to the sponsor and repeatedly or deliberately failed to comply with the cited [federal] regulations, which placed unnecessary risks to human subjects and jeopardized the integrity of data."1 The infractions were serious: forged or missing signatures; falsified records of physical examinations, electrocardiograms, and laboratory results; enrolling of patients without adequate checks on their eligibility; and disappearance of over two hundred tablets of investigational drugs. Ultimately Berger proved that the fraud was traceable to a research coordinator who was embezzling research subjects' stipends. But Berger had not adequately supervised the employee's work and had failed to uncover his criminal record in pre-employment screening. After months of negotiations, the FDA agreed that Berger could continue conducting drug studies, with the stipulation that an outside monitor review his work.

So how was the fraud uncovered? In 2008 and 2009, a clinical trials monitor noted anomalies in signatures on consent forms and other documents and reported these findings to the FDA, which began an investigation. Here the irregularities were paired with and concealed by forged signatures, making them relatively easy to uncover in routine monitoring. But noncompliance may not always occur in tandem with surface irregularities and may not be visible unless a monitor can secure access to the "backstage" of a clinic's operation. It is the process and effects of getting backstage that this article explores.

Seemingly detached from the serious work of science and treatment, the regulatory encounters we discuss entail arcane rules and endless paperwork. Such regulatory work is just the place where we might expect ritualistic adherence to the "letter of the law." In fact, though, the stakes are very high and regulatory encounters can move well beyond ritualism, as Berger and his research coordinator learned. Clinical research and treatment programs are multimillion dollar enterprises. Without assurance of ethical and scientific integrity in data collection, clinical trial results cannot withstand FDA scrutiny, jeopardizing patients' access to safe and effective drugs and therapies. For government and industry sponsors, regulatory inspections provide crucial evidence that they have invested in scientifically and ethically sound research. And as Berger's case illustrates, researchers' and clinics' access to future research and treatment funding depends on demonstrated compliance with regulations. Mostly the stakes of regulation remain as background in the encounters between monitors and clinic workers. But episodically, clinic staffworried about how they could continue vital work if they lost funding and monitors reflected on their pride in ensuring the integrity of important medical research.

The rest of this article is only available to active members of Questia

Sign up now for a free, 1-day trial and receive full access to:

  • Questia's entire collection
  • Automatic bibliography creation
  • More helpful research tools like notes, citations, and highlights
  • Ad-free environment

Already a member? Log in now.

Notes for this article

Add a new note
If you are trying to select text to create highlights or citations, remember that you must now click or tap on the first word, and then click or tap on the last word.
One moment ...
Project items

Items saved from this article

This article has been saved
Highlights (0)
Some of your highlights are legacy items.

Highlights saved before July 30, 2012 will not be displayed on their respective source pages.

You can easily re-create the highlights by opening the book page or article, selecting the text, and clicking “Highlight.”

Citations (0)
Some of your citations are legacy items.

Any citation created before July 30, 2012 will labeled as a “Cited page.” New citations will be saved as cited passages, pages or articles.

We also added the ability to view new citations from your projects or the book or article where you created them.

Notes (0)
Bookmarks (0)

You have no saved items from this article

Project items include:
  • Saved book/article
  • Highlights
  • Quotes/citations
  • Notes
  • Bookmarks
Notes
Cite this article

Cited article

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

(Einhorn, 1992, p. 25)

(Einhorn 25)

1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited article

Performing Regulation: Transcending Regulatory Ritualism in HIV Clinics
Settings

Settings

Typeface
Text size Smaller Larger
Search within

Search within this article

Look up

Look up a word

  • Dictionary
  • Thesaurus
Please submit a word or phrase above.
Print this page

Print this page

Why can't I print more than one page at a time?

Full screen

matching results for page

Cited passage

Style
Citations are available only to our active members.
Sign up now to cite pages or passages in MLA, APA and Chicago citation styles.

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn, 1992, p. 25).

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences." (Einhorn 25)

"Portraying himself as an honest, ordinary person helped Lincoln identify with his audiences."1

1. Lois J. Einhorn, Abraham Lincoln, the Orator: Penetrating the Lincoln Legend (Westport, CT: Greenwood Press, 1992), 25, http://www.questia.com/read/27419298.

Cited passage

Welcome to the new Questia Reader

The Questia Reader has been updated to provide you with an even better online reading experience.  It is now 100% Responsive, which means you can read our books and articles on any sized device you wish.  All of your favorite tools like notes, highlights, and citations are still here, but the way you select text has been updated to be easier to use, especially on touchscreen devices.  Here's how:

1. Click or tap the first word you want to select.
2. Click or tap the last word you want to select.

OK, got it!

Thanks for trying Questia!

Please continue trying out our research tools, but please note, full functionality is available only to our active members.

Your work will be lost once you leave this Web page.

For full access in an ad-free environment, sign up now for a FREE, 1-day trial.

Already a member? Log in now.